Helene Depui

Title: Helene Depui: Innovator in Pharmaceutical Formulations

Introduction

Helene Depui is a prominent inventor based in Göteborg, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. With a total of 7 patents to her name, her work focuses on improving the efficacy and safety of medications.

Latest Patents

One of her latest patents involves oral pharmaceutical dosage forms that combine a proton pump inhibitor with a non-steroidal anti-inflammatory drug (NSAID). This innovative formulation features an acid-susceptible proton pump inhibitor that is protected by an enteric coating layer. The fixed formulation can be presented as an enteric-coated layered tablet, a capsule, or a multiple unit tableted dosage form, with the latter being the most preferred option. This new fixed formulation is particularly beneficial in treating gastrointestinal side effects associated with NSAID treatment.

Career Highlights

Throughout her career, Helene has worked with notable companies such as AstraZeneca AB and Astra Aktiebolag. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to the development of effective drug formulations.

Collaborations

Helene has collaborated with esteemed colleagues, including Per Johan Lundberg and Agneta Hallgren. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Helene Depui's contributions to pharmaceutical innovations, particularly in oral dosage forms, have made a significant impact on the industry. Her work continues to pave the way for safer and more effective treatments for patients.